Italy was one of the most affected nations by coronavirus disease 2019 outside China. The infections, initially limited to Northern Italy, spread to all other Italian regions. This study aims to provide a snapshot of severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) epidemiology based on a single-center laboratory experience in Rome. The study retrospectively included 6565 subjects tested for SARS-CoV-2 at the Laboratory of Virology of Sapienza University Hospital in Rome from 6 March to 4 May. A total of 9995 clinical specimens were analyzed, including nasopharyngeal swabs, bronchoalveolar lavage fluids, gargle lavages, stools, pleural fluids, and cerebrospinal fluids. Positivity to SARS-CoV-2 was detected in 8% (527/6565) of individuals, increased with age, and was higher in male patients (P <.001). The number of new confirmed cases reached a peak on 18 March and then decreased. The virus was detected in respiratory samples, in stool and in pleural fluids, while none of gargle lavage or cerebrospinal fluid samples gave a positive result. This analysis allowed to gather comprehensive information on SARS-CoV-2 epidemiology in our area, highlighting positivity variations over time and in different sex and age group and the need for a continuous surveillance of the infection, mostly because the pandemic evolution remains unknown.

SARS-CoV-2 diagnostics in the virology laboratory of a University Hospital in Rome during the lockdown period / Turriziani, O.; Sciandra, I.; Mazzuti, L.; Di Carlo, D.; Bitossi, C.; Calabretto, M.; Guerrizio, G.; Oliveto, G.; Riveros Cabral, R. J.; Viscido, A.; Falasca, F.; Gentile, M.; Pietropaolo, V.; Rodio, D. M.; Carattoli, A.; Antonelli, G.. - In: JOURNAL OF MEDICAL VIROLOGY. - ISSN 0146-6615. - (2021). [10.1002/jmv.26332]

SARS-CoV-2 diagnostics in the virology laboratory of a University Hospital in Rome during the lockdown period

Turriziani O.;Sciandra I.;Mazzuti L.;Di Carlo D.;Bitossi C.;Calabretto M.;Guerrizio G.;Oliveto G.;Riveros Cabral R. J.;Viscido A.;Falasca F.;Gentile M.;Pietropaolo V.;Rodio D. M.;Carattoli A.;Antonelli G.
2021

Abstract

Italy was one of the most affected nations by coronavirus disease 2019 outside China. The infections, initially limited to Northern Italy, spread to all other Italian regions. This study aims to provide a snapshot of severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) epidemiology based on a single-center laboratory experience in Rome. The study retrospectively included 6565 subjects tested for SARS-CoV-2 at the Laboratory of Virology of Sapienza University Hospital in Rome from 6 March to 4 May. A total of 9995 clinical specimens were analyzed, including nasopharyngeal swabs, bronchoalveolar lavage fluids, gargle lavages, stools, pleural fluids, and cerebrospinal fluids. Positivity to SARS-CoV-2 was detected in 8% (527/6565) of individuals, increased with age, and was higher in male patients (P <.001). The number of new confirmed cases reached a peak on 18 March and then decreased. The virus was detected in respiratory samples, in stool and in pleural fluids, while none of gargle lavage or cerebrospinal fluid samples gave a positive result. This analysis allowed to gather comprehensive information on SARS-CoV-2 epidemiology in our area, highlighting positivity variations over time and in different sex and age group and the need for a continuous surveillance of the infection, mostly because the pandemic evolution remains unknown.
2021
COVID-19; epidemiology; laboratory diagnostics; SARS-CoV-2
01 Pubblicazione su rivista::01a Articolo in rivista
SARS-CoV-2 diagnostics in the virology laboratory of a University Hospital in Rome during the lockdown period / Turriziani, O.; Sciandra, I.; Mazzuti, L.; Di Carlo, D.; Bitossi, C.; Calabretto, M.; Guerrizio, G.; Oliveto, G.; Riveros Cabral, R. J.; Viscido, A.; Falasca, F.; Gentile, M.; Pietropaolo, V.; Rodio, D. M.; Carattoli, A.; Antonelli, G.. - In: JOURNAL OF MEDICAL VIROLOGY. - ISSN 0146-6615. - (2021). [10.1002/jmv.26332]
File allegati a questo prodotto
File Dimensione Formato  
Turriziani_SARS-CoV-2_2020.pdf

accesso aperto

Tipologia: Versione editoriale (versione pubblicata con il layout dell'editore)
Licenza: Creative commons
Dimensione 1.03 MB
Formato Adobe PDF
1.03 MB Adobe PDF

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11573/1444578
Citazioni
  • ???jsp.display-item.citation.pmc??? 11
  • Scopus 12
  • ???jsp.display-item.citation.isi??? 12
social impact